Contact

Prof. Dr. Janosch Hildebrand

  • Smiling warmly at the camera, a person with short grayish hair and a light blue button-up shirt stands in front of a softly blurred indoor setting, suggesting they might be on campus at Hochschule Coburg, where hints of greenery and light create an inviting atmosphere.

Quicklinks

Teaching and research areas ›
Functions at the university ›
Courses ›
Short vita ›
Main research areas ›

Teaching and research areas

  • Pharmacology & Toxicology
  • Clinical analytics
  • Systems Biology & Cell Biology
  • Molecular biology of ageing
  • Innovation management
  • Business Analytics

Functions at the university

Courses

  • Introduction to computer science
  • Programming
  • Modeling and simulation

Short vita

  • since 2017: Professor of Biomedical Analytics at Coburg University of Applied Sciences
  • 2015-2017: Senior R&D Performance Manager, Department Strategy & Business Operations, Merck KGaA, Darmstadt
  • 2014-2015: R&D Controller & Strategic Project Manager, Department R&D Controlling, Beiersdorf AG, Hamburg
  • 2011-2014: Research Scientist & Project Manager, Department Applied Skin Biology, Beiersdorf AG, Hamburg
  • 2007-2010: PhD program of Beiersdorf AG in cooperation with the Heinrich Pette Institute, Hamburg

Main research areas

Prof. Dr. Janosch Hildebrand works on issues relating to molecular pharmacology and ageing research as well as innovation management in pharmaceutical development and the health care industry.
In molecular pharmacology and ageing research, his focus is on the development of complex cell culture systems to optimize drug testing and development.
These model systems are studied and combined with systems biology approaches from gene expression, proteome and metabolome analysis in order to identify therapeutically relevant cellular processes and target molecules.
Prof. Hildebrand is a member of the Sensor Technology and Analytics research focus area at Coburg University of Applied Sciences.

In the field of innovation management in pharmaceutical development and the health care industry, he is primarily concerned with the development of digital services for the optimization and control of development processes and the identification of new areas of application.